ADL Pharma

Leuven ·KBO/BCE: BE 1004.847.744

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	3.5%	37.4%	better than 11% of 1407 sector peers
Net result	€17k	€46k	better than 37% of 1406 sector peers
Equity	€20k	€362k	better than 13% of 1407 sector peers
Gross operating margin	€39k	€65k	better than 39% of 1405 sector peers
Total assets	€569k	€1.41M	better than 30% of 1407 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€569k
Fixed assets	21/28	€533k
Formation expenses	20	€43
Financial fixed assets	28	€533k
Current assets	29/58	€37k
Cash & bank	54/58	€28k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€569k
Equity	10/15	€20k
Contributions / capital	10/11	€3k
Accumulated profits (losses)	14	€17k
Amounts payable	17/49	€549k
Amounts payable after one year	17	€377k
Amounts payable within one year	42/48	€168k
Trade debts payable within one year	44	€198
Income statement
Gross operating margin	9900	€39k
Operating result	9901	€37k
Financial charges	65	€16k
Result before taxes	9903	€22k
Income taxes	67/77	€5k
Net result for the period	9904	€17k
Result to be appropriated	9905	€17k

Summary